Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Scientists Create New Map of Brain Region Linked to Alzheimer’s Disease

By University of Southern California | October 8, 2018

Curing some of the most vexing diseases first requires navigating the world’s most complex structure – the human brain. So, USC scientists have created the most detailed atlas yet of the brain’s memory bank.

Cartographers of the cranium, a USC research team has illustrated the internal circuitry of the hippocampus in detail that would make the great ancient mapmaker, Ptolemy, proud. Using fluorescent tracers and 3-D animation, the scientists show structures, nerve connections and functions in vivid detail. The study appears today in the journal Nature Neuroscience.

“Like a new atlas, we’ve constructed the most detailed diagram of the hippocampus to date,” said Michael S. Bienkowski, lead author of the study and a researcher at the USC Institute for Neuroimaging and Informatics in the Keck School of Medicine of USC. “With a better map, we can see each region and how it functions. A better map is a resource scientists can use to better understand the hippocampus and how its degeneration leads to diseases.”

The human hippocampus sits at the base of the brain and it’s shaped like a seahorse. It stores memories, helps regulate emotions and guides navigation by spatial processing. It’s the first part of the brain impaired by Alzheimer’s and hippocampus degeneration can cause epilepsy and other diseases.

In this case, scientists worked on a mouse brain because it’s organized similar to a human brain. Scientists can use the new map of the hippocampus to deliver genetically-targeted drugs to specific neurons with fewer side effects, said senior author, Hong-Wei Dong, USC professor of neurology and director of the USC Center for Integrated Connectomics (CIC).

The work is part of the Mouse Connectome Project, a USC-led effort that collects lots of data about neural connections in the brain and shares it publicly with researchers in more than 100 countries. Disconnections in the brain underlie Huntington’s disease, Parkinson’s disease, Alzheimer’s disease, autism spectrum disorders and many other illnesses.

Scientists have known the basic four-part architecture of the hippocampus for a long time. What’s different now is the USC scientists can show its sub-regions and how nerve cells interact across the structure. It’s a night-and-day difference, akin to seeing transmission lines and power poles slung across a city by day compared to fully illuminated at night. This new visualization traces neural pathways and connections in remarkable detail using fluorescent dyes as tracers that reveal cells, neuron junctions and connections to the rest of the brain.

“It totally changes our understanding by combining a wiring diagram with gene expression of the mouse hippocampus. We see it doing different things, and this gives us a new way to understand how the whole thing works together. This should have a very profound and broad impact,” Bienkowski said.

Alzheimer’s disease is the sixth leading cause of death for older people and the leading cause of dementia in the United States, according to the National Institute on Aging. It accounts for 93,500 deaths nationwide annually, and the prevalence and rate of death is increasing as the population ages, according to the U.S. Centers for Disease Control and Prevention.

The Mouse Connectome Project at USC is part of a larger effort funded by the National Institutes of Health to map all the connections of the brain to understand how different structures network to regulate behavior. Dong’s research focuses on how to classify neurons based on both genetics and connectivity, information that could help other researchers develop strategies to target neurons to treat diseases in humans. The work is parallel to a Human Connectome Project, involving 100 researchers at leading research institutions with $40 million from the National Institutes of Health, that maps brain connections in humans.

The human brain contains about 100 billion neurons, each with about 10,000 connections, so mapping this network is a big-data challenge involving many scientists. USC’s contribution helps advance the larger effort by starting with a simpler task such as the mouse hippocampus research.


Filed Under: Neurological Disease

 

Related Articles Read More >

Human study tracks brain’s glymphatic flow in real time, opening Alzheimer’s drug avenues
An 8-year-old patient with gangliosidosis demonstrates improved mobility, walking unassisted on a soccer field after treatment with N-acetyl-L-leucine. (Still from video footage; parental consent obtained for use).
Modified amino acid approved for Niemann–Pick shows promise in early Parkinson’s research
AI-guided hunt points to PHGDH as an upstream drug target in Alzheimer’s disease
Why smaller, simpler molecular glues are gaining attention in drug discovery
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE